| Budget Amount *help |
¥19,500,000 (Direct Cost: ¥15,000,000、Indirect Cost: ¥4,500,000)
Fiscal Year 2013: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2012: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000)
Fiscal Year 2011: ¥8,320,000 (Direct Cost: ¥6,400,000、Indirect Cost: ¥1,920,000)
|
|---|
| Research Abstract |
Through the analysis of mice deficient in the fourth lysophosphatidic receptor (LPA4), we previously revealed that LPA4 is involved in development of type 2 diabetes. In this study, we found that LPA4 negatively regulates mitochondria biogenesis by activating the Rho/Rho kinase pathway and then suppresses adipogenesis. LPA4 antagonists are expected to promote adipogenesis and may be useful for the treatment of patients with type 2 diabetes. In this study, therefore, we screened LPA4 antagonists from a chemical library.
|
